Reading the repertoire: Progress in adaptive immune receptor analysis using machine learning

TJ O'Donnell, C Kanduri, G Isacchini, JP Limenitakis… - Cell Systems, 2024 - cell.com
The adaptive immune system holds invaluable information on past and present immune
responses in the form of B and T cell receptor sequences, but we are limited in our ability to …

Next-generation therapeutic antibodies for cancer treatment: advancements, applications, and challenges

A Raja, A Kasana, V Verma - Molecular Biotechnology, 2024 - Springer
The field of cancer treatment has evolved significantly over the last decade with the
emergence of next-generation therapeutic antibodies. Conventional treatments like …

AIntibody: an experimentally validated in silico antibody discovery design challenge

MF Erasmus, L Spector, F Ferrara, R DiNiro… - Nature …, 2024 - nature.com
Science is frequently subject to the Gartner hype cycle 1: emergent technologies spark
intense initial enthusiasm with the recruitment of dedicated scientists. As limitations are …

[HTML][HTML] The Application of Machine Learning on Antibody Discovery and Optimization

J Zheng, Y Wang, Q Liang, L Cui, L Wang - Molecules, 2024 - mdpi.com
Antibodies play critical roles in modern medicine, serving as diagnostics and therapeutics
for various diseases due to their ability to specifically bind to target antigens. Traditional …

Digital Transformation in the Biopharmaceutical Industry: Rebuilding the Way We Discover Complex Therapeutics

T Frolov, L Wossnig, A Jung - Biopharmaceutical Informatics, 2025 - taylorfrancis.com
The biopharmaceutical sector, driven by the possibility of curing diseases, has made
tremendous progress over the last decades: the first biosynthetic human insulin in 1982; the …

The Artificial Intelligence Revolution: Transforming the Design and Optimization of Multispecific Antibodies

P Greisen, Z Pang, F Garces - Biopharmaceutical Informatics, 2025 - taylorfrancis.com
Artificial intelligence (AI) is rapidly transforming protein engineering, impacting our approach
to the development of therapeutic monoclonal antibodies (mAb). Industrial workflows for the …

[BOOK][B] Biopharmaceutical Informatics: Learning to Discover Developable Biotherapeutics

S Kumar, A Nixon - 2025 - books.google.com
Despite the phenomenal clinical success of antibody-based biopharmaceuticals in recent
years, discovery and development of these novel biomedicines remains a costly, time …